AdvertisementWhat's behind the FDA's controversial strategy for evaluating new COVID boostersAugust 18, 2022Rob SteinfacebookEmailThe federal government wants to roll out another round of COVID-19 boosters this fall but drugmakers are still testing the new boosters. The Food and Drug Administration has said it will base its evaluation of the boosters on data from mouse studies, in a controversial move. (Getty Images)